1-3 of 3
The GOELAMS Group
Close
Sort by
Journal Articles

Clinical Features and Prognostic Factors in 135 NHL of the Head and Neck Treated by the GOELAMS 02 Trial.

Laurent Laccourreye, MD, Bernard Desablens, MD, Christine Le Maignan, MD, Anne Le Mevel, MD, Christian Berthou, MD, Thierry Lamy, MD-PhD, Christiane Ghandour, François Guilhot, MD, Mathilde Hunault-Berger, MD-PhD, Henry Jardel, MD, Norbert Ifrah, MD, Philippe Colombat, MD, The GOELAMS Group
Journal: Blood
Blood (2005) 106 (11): 942.
https://doi.org/10.1182/blood.V106.11.942.942
Published: 2005
Journal Articles

High Dose and Conventional Anthracycline Regimen for Adult Non-Hodgkin’s Primary Bone Lymphoma (PBL). A GOELAMS’s Trial.

Aline Schmidt-Tanguy, MD, Bernard Desablens, MD, Thierry Lamy, MD-PhD, Marc Bernard, MD, Delphine Senecal, MD, Jean-Francois Abgrall, MD, Philippe Casassus, MD, Jacqueline Dugay, MD, Philippe Rodon, MD, Mathilde Hunault-Berger, MD-PhD, Norbert Ifrah, MD, the GOELAMS Group, Philippe Colombat, MD-PhD
Journal: Blood
Blood (2004) 104 (11): 2495.
https://doi.org/10.1182/blood.V104.11.2495.2495
Published: 2004
Journal Articles

Evolution of Antithrombin (AT) and Fibrinogen (Fg) Levels during Induction Chemotherapy with L-Asparaginase (Asp) in Adult Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL). Clinical Outcomes and Use of Coagulation Supportive Treatments: The CAPELAL Study.

Mathilde Hunault-Berger, MD-PhD, Yves Gruel, MD, Jean-Luc Harousseau, MD, Martine Delain, MD, Abdallah Maakaroun, MD, Claude-Eric Bulabois, MD, Francis Witz, MD, Marc Bernard, MD, Ingrid Lafon, Jerome Cornillon, MD, Abdel Ladouzi, Alexandra Tizon, Bruno Padrazzi, Zera Tellier, MD, Norbert Ifrah, MD, the GOELAMS group
Journal: Blood
Blood (2004) 104 (11): 4486.
https://doi.org/10.1182/blood.V104.11.4486.4486
Published: 2004